 Print View Attached Docs: |
|||||||||
| 82845:HUMAN PAPILLOMA VIRUS (HPV), HIGH RISK DETECTR™, ANAL/RECTAL | |||||||||
| Methodology: | Hybrid Capture (HC) | ||||||||
| Edit Date: | 9/30/2010 | ||||||||
| Performed: | Tuesday-Sunday | ||||||||
| Released: | 48-72 hours after setup at PeaceHealth Laboratories’ reference lab. | ||||||||
| CPT Code: | 87621-90 | ||||||||
| Specimen Collection Details | |||||||||
| Collection: | Anal and rectal swab specimen using a Digene Specimen Collection Kit and transported in the Digene Specimen Transport Medium. Also acceptable: ThinPrep vial. | ||||||||
| Stability: | Digene Media: 14 days ambient, 21 days refrigerated, or 3 months frozen.
ThinPrep Vial: 21 days ambient, 21 days refrigerated. Unstable frozen. |
||||||||
| Standard Volume: | Digene Media: 1 mL medium ThinPrep: 4 mL medium. |
||||||||
| Transport: | Refrigerated. | ||||||||
| Comments: | The majority of anal cancers are squamous cell carcinomas (in situ and epidermoid), which are usually associated with HPV. | ||||||||
| Rejection Criteria: | Specimen in SurePath. | ||||||||